Korean Stock Flows

Korea United Pharm (KRX: 033270)

유나이티드제약 KOSPI Biotech & Pharma 의약품 제조업
Close (Oct 16, 2026)
₩17,740
+2.37%
Market cap
₩0T ($0.2B)
52-week range
₩16,100 – ₩21,800
P/E (12M fwd) · P/B · Div yield
6.62 · 0.62 · 3.44%
trailing 6.79 · consensus of 1 analysts

Who is buying Korea United Pharm?

Between Sep 15, 2026 and Oct 16, 2026 (20 trading sessions), foreign investors net sold ₩0.3bn ($0M) of Korea United Pharm, the 315th largest foreign net sale among 832 KOSPI stocks. Institutions net sold ₩0.1bn ($0M) and retail investors net bought ₩0.3bn ($0M) over the same window. Foreigners were net buyers on 9 of the 20 sessions.

Foreign investors hold 8.7% of Korea United Pharm's listed shares (KRX ownership data as of Oct 16, 2026), down from 8.92% twenty sessions earlier and 6.2% a year ago.

The stock closed at ₩17,740 on Oct 16, 2026: -2.53% over 20 sessions, -6.97% year-to-date, -8.08% over one year. The 52-week range is ₩16,100 – ₩21,800.

At ₩17,740 the stock trades at 6.62× 12-month-forward consensus earnings (1 analysts), 6.67× on FY2027 estimates. The trailing P/E published by KRX is 6.79×, based on the last completed fiscal year.

Korea United Pharm share price, last 60 trading days (KRW)
18,591 18,024 17,456 16,889 Jul 16 Aug 31 Oct 16
Daily foreign investor net purchases, last 60 trading days
+0.5bn +0.3bn -0.3bn -0.5bn Jul 16 Aug 31 Oct 16
View chart data as a table
Date Close Foreign net Institutions Retail
2026-10-16 ₩17,740 +₩0.2bn ₩-0.0bn ₩-0.2bn
2026-10-15 ₩17,330 +₩0.2bn +₩0.0bn ₩-0.3bn
2026-10-14 ₩17,440 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-10-13 ₩17,500 +₩0.2bn ₩-0.0bn ₩-0.1bn
2026-10-12 ₩17,750 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-10-08 ₩17,860 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-10-07 ₩17,970 +₩0.2bn ₩-0.0bn ₩-0.2bn
2026-10-06 ₩17,740 +₩0.0bn +₩0.0bn +₩0.0bn
2026-10-02 ₩17,530 ₩-0.3bn ₩-0.0bn +₩0.3bn
2026-10-01 ₩17,720 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-09-30 ₩17,700 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-09-29 ₩17,690 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-09-28 ₩17,630 +₩0.1bn ₩-0.1bn +₩0.1bn
2026-09-23 ₩17,630 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-09-22 ₩17,650 ₩-0.4bn +₩0.0bn +₩0.4bn
2026-09-21 ₩17,940 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-09-18 ₩17,930 +₩0.1bn ₩-0.0bn ₩-0.0bn
2026-09-17 ₩17,900 ₩-0.0bn +₩0.0bn ₩-0.0bn
2026-09-16 ₩18,020 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-09-15 ₩17,970 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-09-14 ₩18,200 +₩0.0bn +₩0.1bn ₩-0.1bn
2026-09-11 ₩18,110 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-09-10 ₩18,380 ₩-0.0bn +₩0.1bn ₩-0.1bn
2026-09-09 ₩18,470 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-09-08 ₩18,270 ₩-0.1bn +₩0.1bn ₩-0.0bn
2026-09-07 ₩18,230 ₩-0.2bn +₩0.1bn +₩0.1bn
2026-09-04 ₩18,500 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-09-03 ₩18,470 +₩0.3bn +₩0.1bn ₩-0.4bn
2026-09-02 ₩18,260 +₩0.2bn +₩0.1bn ₩-0.3bn
2026-09-01 ₩18,160 +₩0.1bn +₩0.1bn ₩-0.2bn
2026-08-31 ₩17,780 ₩-0.1bn +₩0.0bn +₩0.0bn
2026-08-28 ₩17,860 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-08-27 ₩17,720 ₩-0.4bn ₩-0.0bn +₩0.4bn
2026-08-26 ₩18,050 +₩0.2bn +₩0.0bn ₩-0.2bn
2026-08-25 ₩17,880 ₩-0.2bn +₩0.0bn +₩0.2bn
2026-08-24 ₩18,060 +₩0.0bn ₩0.0bn ₩-0.1bn
2026-08-21 ₩17,910 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-08-20 ₩18,160 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-08-19 ₩18,010 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-08-18 ₩18,300 ₩-0.2bn +₩0.0bn +₩0.1bn
2026-08-14 ₩18,360 +₩0.3bn ₩-0.1bn ₩-0.1bn
2026-08-13 ₩18,170 ₩-0.1bn ₩-0.1bn +₩0.2bn
2026-08-12 ₩18,400 ₩-0.3bn ₩-0.0bn +₩0.3bn
2026-08-11 ₩18,410 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-08-10 ₩18,350 ₩-0.0bn ₩-0.0bn +₩0.1bn
2026-08-07 ₩18,300 ₩-0.0bn +₩0.0bn ₩0.0bn
2026-08-06 ₩17,970 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-05 ₩17,780 ₩-0.0bn ₩-0.0bn +₩0.1bn
2026-08-04 ₩17,880 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-08-03 ₩17,730 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-07-31 ₩17,850 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-07-30 ₩17,500 +₩0.5bn +₩0.0bn ₩-0.4bn
2026-07-29 ₩17,080 +₩0.5bn +₩0.0bn ₩-0.6bn
2026-07-28 ₩17,300 +₩0.1bn ₩0.0bn ₩-0.2bn
2026-07-27 ₩17,510 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-07-24 ₩17,490 +₩0.0bn +₩0.0bn ₩-0.1bn
2026-07-23 ₩17,410 +₩0.2bn ₩-0.0bn ₩-0.1bn
2026-07-22 ₩16,980 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-07-21 ₩17,010 ₩-0.0bn ₩-0.0bn +₩0.1bn
2026-07-20 ₩17,180 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-07-16 ₩17,580 ₩-0.1bn ₩-0.0bn +₩0.1bn

Investor flows summary

Window Foreign (USD) Institutions Retail
1 day +₩0.2bn +$0M ₩-0.0bn ₩-0.2bn
5 days +₩0.3bn +$0M +₩0.1bn ₩-0.4bn
20 days ₩-0.3bn $-0M ₩-0.1bn +₩0.3bn

Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.

Frequently asked questions

Are foreign investors buying Korea United Pharm stock?

Over the last 5 sessions foreign investors net bought ₩0.3bn ($0M) of Korea United Pharm; over 60 sessions they net bought ₩0.5bn ($0M); since Jan 1, 2026 they net bought ₩3.8bn ($3M). Over 20 sessions the stock is the 315th largest foreign net sale among 832 KOSPI stocks.

How much of Korea United Pharm do foreign investors own?

Foreign investors own 8.7% of Korea United Pharm's shares as of Oct 16, 2026, versus 6.2% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.

Who is on the other side — institutions or retail investors?

Over 20 sessions institutions net sold ₩0.1bn ($0M) and retail investors net bought ₩0.3bn ($0M) of Korea United Pharm. Retail investors have been absorbing what foreigners and institutions are selling.

Is Korea United Pharm listed on KOSPI or KOSDAQ?

Korea United Pharm (유나이티드제약) trades on KOSPI under KRX code 033270 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.2B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.

Annual financials

Fiscal year Revenue YoY Operating profit Net income
2023 ₩279bn ($207M) – ₩55bn ($41M) ₩48bn ($36M)
2024 ₩289bn ($215M) +3.50% ₩56bn ($42M) ₩32bn ($24M)
2025 ₩289bn ($215M) 0.00% ₩50bn ($37M) ₩38bn ($28M)

Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1345.9/$) for reference only.

← All foreign investor flows